|
|
|
4527 ROHTO PHARMACEUTICAL CO.,LTD.
|
|
| 05/29/2026 15:30 |
Completion of Share Acquisition of Thann Oryza Co., Ltd. |
| 05/21/2026 15:30 |
Notice Regarding Adjustment of Conversion Price for \25,000,000,000 Zero Coupon Convertible Bonds Due 2032 |
| 05/21/2026 15:30 |
Notice of Dividend of Surplus |
| 05/13/2026 15:30 |
Notice of Revision of Dividend Forecast (Dividend Increase) |
| 05/13/2026 15:30 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 |
| 04/30/2026 19:00 |
Notice of Receipt of Shareholder Proposals |
| 03/26/2026 15:30 |
Notice Regarding the Repurchase of Shares |
| 02/12/2026 15:30 |
Financial Results Briefing for Q3 of FY2026 (April-December) |
| 02/12/2026 15:30 |
Notice of Revision of Earnings Forecast and Revision of Dividend Forecast (Dividend Increase) |
| 02/12/2026 15:30 |
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (Nine Months Ended December 31, 2025) |
| 01/07/2026 15:30 |
Acquisition of shares (subsidiarization) of a Thailand-based wellness-related company, Thann Oryza Co., Ltd. |
| 11/13/2025 15:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 11/13/2025 15:30 |
ROHTO Pharmaceutical Acquires OBAGI-Related Trademarks in Japan |
| 11/13/2025 15:30 |
Financial Results Briefing for 1stHalf of FY2026(April -September) |
| 11/13/2025 15:30 |
Notice of Revision of Earnings Forecast and Revision of Dividend Forecast (Dividend Increase) |
| 08/06/2025 15:30 |
Notice of Revision of Earnings Forecast |
| 08/06/2025 15:30 |
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 |
| 06/30/2025 18:00 |
Corporate Governance Report |
| 06/03/2025 08:00 |
NOTICE OF CONVOCATION THE 89TH ORDINARY GENERAL MEETING OF SHAREHOLDERS |
|